For the quarter ending 2025-09-30, MDCXW has $9,977,661 in assets. $10,782,551 in debts. $8,662,091 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents, end of year | 8,662,091 | 9,669,546 | ||
| Prepaid expense, current | 1,119,321 | 1,327,185 | ||
| Total current assets | 9,781,412 | 10,996,731 | ||
| Operating lease, right-of-use asset | 196,249 | 220,999 | ||
| Deferred costs, noncurrent | - | 716,898 | ||
| Assets | 9,977,661 | 11,934,628 | ||
| Accounts payable, current | 2,027,509 | 1,770,178 | ||
| Accrued and other accounts payable | 1,560,430 | 1,828,312 | ||
| Represents the related party payable | 143,080 | 121,273 | ||
| Operating lease, liability, current | 141,070 | 124,402 | ||
| Ending balance | 6,785,812 | 4,700,000 | ||
| Liabilities, current | 10,657,901 | 8,544,165 | ||
| Loans payable, noncurrent | 29,462 | - | ||
| Operating lease, liability, noncurrent | 95,188 | 141,753 | ||
| Total liabilities | 10,782,551 | 8,685,918 | ||
| Common stock, value, issued | 4 | 37,833,999 | ||
| Represents the amount of common shares to be issued | 313,934 | - | ||
| Additional paid-in capital | 6,449,863 | 5,597,106 | ||
| Accumulated other comprehensive income (loss), net of tax | 10,676 | - | ||
| Accumulated deficit | -5 | -40,182,395 | ||
| Equity, attributable to parent | -910,126 | - | ||
| Equity, attributable to noncontrolling interest | 105,236 | - | ||
| Ending balance | -804,890 | 3,248,710 | ||
| Total liabilities and shareholders' deficit | 9,977,661 | 11,934,628 | ||
Medicus Pharma Ltd. (MDCXW)
Medicus Pharma Ltd. (MDCXW)